In PDAC, both insulin and IGF-1 are considered to play a role in cancer development and progression, with the PI3K and MAPK signaling pathways as its central pathways, and these signals are enhanced in obesity (61, 62). Here, IGF1 is linked to obesity due to melanocortin 4 receptor deficiency.